GLP-1 drugs like semaglutide, tirzepatide, and liraglutide mainly cause GI symptoms, nausea, vomiting, diarrhea, constipation, bloating, and can rarely lead to pancreatitis, gallbladder disease, or kidney issues
Women show unique side-effects to many pharmacotherapies, and still [in] most studies women are often underrepresented at various stages of testing, Skibicka added
Some insurers could take months to add the drugs to their plans or decide not to pay for them
Notably, FGF21 analogs have reduced insulin resistance or decreased liver fat in clinical trials 16,26
Its also approved to lower the risk of cardiovascular problems in people with type 2 diabetes and heart disease